Gemtuzumab ozogamycyny (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Gemtuzumab ozogamycyny" in Polish language version.

refsWebsite

Global rank Polish rank

4^th place

7^th place

2^nd place

6^th place

68^th place

31^st place

719^th place

1,030^th place

87^th place

5^th place

5^th place

2^nd place

archive.is

JK. Lamba, S. Pounds, X. Cao, JR. Downing i inni. Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.. „Leukemia”. 23 (2), s. 402-4, Feb 2009. DOI: 10.1038/leu.2008.185. PMID: 18615103.

Human medicines European public assessment report (EPAR): Mylotarg, gemtuzumab ozogamicin, Leukemia, Myeloid, Acute, Date of authorisation: 19/04/2018, Revision: 3, Status: Authorised, „Case Medical Research”, 2019, DOI: 10.31525/cmr-838f19, ISSN 2643-4652 [dostęp 2019-08-13] .

JK. Lamba, S. Pounds, X. Cao, JR. Downing i inni. Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study.. „Leukemia”. 23 (2), s. 402-4, Feb 2009. DOI: 10.1038/leu.2008.185. PMID: 18615103.
M. Jadhav, B. Cushing, O. Ozdemir, A. Mohamed i inni. Clonal trisomy 11 in a child with acute leukemia: G banding vs. FISH. „Med Pediatr Oncol”. 37 (5), s. 475-6, Nov 2001. PMID: 11745878.

Human medicines European public assessment report (EPAR): Mylotarg, gemtuzumab ozogamicin, Leukemia, Myeloid, Acute, Date of authorisation: 19/04/2018, Revision: 3, Status: Authorised, „Case Medical Research”, 2019, DOI: 10.31525/cmr-838f19, ISSN 2643-4652 [dostęp 2019-08-13] .